Figure 1.
Effect of combined pharmacological blockade of nitric oxide and histamine production on flow-dependent relaxation of mesenteric lymphatic vessels.
A – lymphatic tone index; B – contraction amplitude; C- contraction frequency; D – fractional pump flow.
Control – control MLVs after overnight culture;
L-NAME – same control vessels after subsequent acute pharmacological blockade of NO production by the nitric oxide synthase non-specific blocker, L-NAME (100 μM);
a-MHD – MLVs after overnight pharmacological blockade of histamine production by HDC specific blocker, α-MHD in 10 μM;
a-MHD + L-NAME – same α-MHD-treated vessels after subsequent acute pharmacological blockade of NO production by nitric oxide synthases non-specific blocker, L-NAME in 100 μM.
* indicates significant differences (P < 0.05) between lymphatic contractile parameters within each treatment group at no-flow and at any imposed flow condition.
+ indicates significant differences (P < 0.05) between lymphatic contractile parameters in any treatment groups and control within any given imposed flow condition.